Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

How to Choose the Right Biotechnology Consultant for Your Project

Sep 04, 2025

Understanding the Role of a Biotechnology Consultant

Biotechnology consultants play a crucial role in guiding businesses through the complexities of biotech projects. From research and development to commercialization, these experts provide insights that can significantly impact your project’s success. They offer strategic advice, industry connections, and technical expertise that help streamline processes and overcome challenges.

biotechnology consultant

Identifying Your Project Needs

Before you begin your search for a biotechnology consultant, it’s essential to clearly define your project goals and requirements. Determine whether you need assistance with regulatory compliance, product development, or market strategy. Having a detailed understanding of your needs will help you find a consultant with the right expertise.

Consider creating a list of specific tasks or challenges you expect the consultant to address. This can include anything from navigating regulatory landscapes to identifying potential partnerships. This clarity will guide your selection process and ensure you choose a consultant who aligns with your objectives.

Researching Potential Consultants

Once you have a clear understanding of your needs, begin researching potential biotechnology consultants. Look for professionals with relevant experience and a proven track record in your specific area of interest. Use industry forums, professional networks, and online platforms to gather recommendations and reviews.

research biotechnology

Consider the consultant's background in terms of education, previous projects, and client feedback. A consultant with experience in similar projects will likely have valuable insights and connections that can benefit your endeavor.

Evaluating Expertise and Experience

When evaluating potential candidates, focus on their expertise and experience in the biotechnology sector. Check their credentials and past project successes to gauge their knowledge and effectiveness. A consultant with specialized experience in your project’s focus area can provide more targeted advice.

Don’t hesitate to ask for references or case studies from past clients. This will provide you with firsthand accounts of their capabilities and effectiveness in delivering results.

consultant evaluation

Assessing Communication Skills

Effective communication is key to any successful partnership. During initial consultations, pay attention to how well the consultant listens to your needs and explains their approach. Clear communication ensures that both parties are on the same page and can collaborate effectively.

Ensure that the consultant is responsive and able to articulate complex concepts in a way that is easy to understand. This will be crucial for aligning your project objectives and achieving desired outcomes.

Considering Budget and Value

Your budget is an important factor when choosing a biotechnology consultant. While cost should not be the sole deciding factor, it’s essential to balance your budget with the value that the consultant brings to your project. Consider the long-term benefits of their expertise against the initial investment.

Discuss pricing structures upfront and ensure there are no hidden fees. A transparent financial arrangement will prevent misunderstandings and help maintain a positive working relationship.

budget planning

Making the Final Decision

After evaluating all aspects, it’s time to make your decision. Choose a biotechnology consultant who not only meets your technical requirements but also fits well with your team’s culture and values. The right consultant will be a collaborative partner who works alongside you to achieve your project goals.

Ultimately, selecting the right biotechnology consultant can significantly influence the success of your project. By following these steps, you’ll be equipped to make an informed decision that aligns with your strategic objectives and propels your project forward.